Lumos Diagnostics Holdings Limited (ASX: LDX)
Sector: Health Care
Market cap: A$59M (as of 2 Nov 2026)
Development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests.
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 15 Sept 2026 | Ryder Capital Ltd and related entities listed in section 4 | Increase | 14.73% → 16.65% | Filing ↗ |
| 14 Apr 2026 | Ryder Capital Ltd and related entities listed in section 4 | Decrease | 17.030% → 14.730% | Filing ↗ |
| 28 Aug 2025 | RYDER CAPITAL LIMITED & ASSOCIATED ENTITIES | Entry | ?% → 17.03% | Filing ↗ |
| 11 Oct 2024 | Tenmile Ventures Pty Ltd (ACN 657 117 130), Tattarang Pty Ltd (ACN 055 961 361) as trustee for The Peepingee Trust (44 994 119 389), Nicola Margaret Forrest, John Andrew Henry Forrest | Increase | 12.39% → 19.93% | Filing ↗ |
| 23 Sept 2024 | Perennial Value Management Limited (PVM) | Exit | — | Filing ↗ |
Director trades — on-market
Cash and runway
Ask about LDX in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has LDX raised money in the last year, and at what discount?
- What was LDX's latest cash position and runway?
Loading LDX…